Francis Wan, Medison’s VP, GM APAC, leads the company’s strategy and operations across the region, working to expand patient access and strengthen partnerships. He brings over 20 years of leadership experience in the biopharmaceutical industry, with deep expertise in commercialization, market access, and business transformation. 
As part of his vast experience, Francis served as President, Asia Pacific (ex-Japan) at Biogen, establishing regional operations and overseeing the launch of rare disease therapies while securing innovative access agreements that expanded patient reach.
His career also includes experience at Boehringer-Ingelheim China, and MSD China, driving business growth, strategic partnerships, and sustainable market access solutions.
Francis has successfully scaled organizations, brought innovative therapies to patients, and built sustainable access models across diverse and complex markets. His extensive experience in Asia Pacific, including deep familiarity with the health landscape in China, has given him a profound understanding of how to navigate complex systems and deliver meaningful impact to patients. His background spans affiliate, regional, and global levels, strengthening his ability to ensure that patients with rare and severe diseases gain access to breakthrough therapies. 
At Medison, Francis plays a central role in advancing the company’s unified global commercialization platform in Asia Pacific. His strategic leadership supports Medison’s mission to bridge critical gaps in global healthcare and deliver transformative innovation to patients in most of the world. 
Francis holds a Bachelor of Science in Accounting from Monmouth University and is both a Certified Public Accountant (CPA) and a Certified Management Accountant (CMA).